Experimental study demonstrates chemoselective diol oxidation using engineered galactose oxidases, highlighting efficient routes for pharmaceutical synthesis without protective groups.
Contains code and structures used in the manuscript "Chemoselectivity in Diol Oxidation: Engineered Galactose Oxidases for Protection-Free Biocatalytic Synthesis of Pharmaceuticals"
No takes yet. Share an insight, caveat, or question.
Shreyas Supekar (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: